QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 190 filers reported holding QIAGEN NV in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,291,000 | +0.5% | 117,424 | -1.6% | 0.00% | 0.0% |
Q3 2016 | $3,274,000 | +20.8% | 119,339 | -4.0% | 0.00% | +33.3% |
Q2 2016 | $2,711,000 | -6.5% | 124,293 | -4.3% | 0.00% | 0.0% |
Q1 2016 | $2,899,000 | -53.2% | 129,814 | -42.0% | 0.00% | -57.1% |
Q4 2015 | $6,189,000 | +10.5% | 223,833 | +3.1% | 0.01% | 0.0% |
Q3 2015 | $5,603,000 | +8.9% | 217,159 | +4.6% | 0.01% | +16.7% |
Q2 2015 | $5,147,000 | +7.4% | 207,648 | +9.2% | 0.01% | +20.0% |
Q1 2015 | $4,793,000 | +6.8% | 190,165 | -0.6% | 0.01% | 0.0% |
Q4 2014 | $4,489,000 | -2.7% | 191,293 | -5.6% | 0.01% | 0.0% |
Q3 2014 | $4,614,000 | +54.0% | 202,632 | +65.3% | 0.01% | +25.0% |
Q2 2014 | $2,996,000 | +15.8% | 122,569 | -0.1% | 0.00% | +33.3% |
Q1 2014 | $2,588,000 | -11.8% | 122,709 | -0.4% | 0.00% | -25.0% |
Q4 2013 | $2,933,000 | -54.9% | 123,144 | -59.5% | 0.00% | -55.6% |
Q3 2013 | $6,501,000 | +18.1% | 303,784 | +9.9% | 0.01% | +12.5% |
Q2 2013 | $5,503,000 | – | 276,432 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |